Use of progesterone treatment for the prevention of recurrent preterm birth: Identification of obstacles to change

American Journal of Perinatology

Volumn 27, Issue 3, 2010, Pages 241-249

  Lim, Arianne C ^a   Goossens, Astrid ^a   Ravelli, Anita C J ^a   Boer, Kees ^a   Bruinse, Hein W ^b   Mol, Ben Willem J ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

Implementation; Preterm birth; Prevention; Progesterone

Indexed keywords

PROGESTERONE;

ADULT; ARTICLE; ATTITUDE; CLINICAL PROTOCOL; FEMALE; HEALTH SURVEY; HORMONAL THERAPY; HUMAN; KNOWLEDGE; MAJOR CLINICAL STUDY; MIDWIFE; PHYSICIAN; POLITICS; PREMATURITY; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RECURRENT DISEASE; SOCIAL ASPECT;

ADULT; ATTITUDE OF HEALTH PERSONNEL; FEMALE; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE; NETHERLANDS; OBSTETRICS; PREGNANCY; PREGNANCY OUTCOME; PREGNANCY, HIGH-RISK; PREMATURE BIRTH; PRENATAL CARE; PROGESTERONE; PROGESTINS; QUESTIONNAIRES; RECURRENCE; TREATMENT OUTCOME; YOUNG ADULT;

EID: 77449144213     PISSN: 07351631     EISSN: 10988785     Source Type: Journal    
DOI: 10.1055/s-0029-1239491     Document Type: Article

References (17)

1. Dutch National Obstetric Registration 2002. Utrecht Prismant 2002
2. Dutch National Neonatal Registration 2002. Utrecht Prismant 2002
3. Martin J A., Hamilton B E., Sutton P D., Ventura S J., Menacker F, Kimeyer S. Births: final data for 2004. National Vital Statistics Reports 2006 2006 Report No.: 55
4. Carr-Hill R A., Hall M H. The repetition of spontaneous preterm labour. Br J Obstet Gynaecol 1985 92 921-928
5. Hoffman H J., Bakketeig L S. Risk factors associated with the occurrence of preterm birth. Clin Obstet Gynecol 1984 27 539-552
6. da Fonseca E B., Bittar R E., Carvalho M H., Zugaib M. Prophylactic administration of progesterone by vaginal suppository to reduce the incidence of spontaneous preterm birth in women at increased risk: a randomized placebo-controlled double-blind study. Am J Obstet Gynecol 2003 188 419-424
7. Meis P J., Klebanoff M, Thom E et al, National Institute of Child Health and Human Development Maternal-Fetal Medicine Units Network. Prevention of recurrent preterm delivery by 17 alpha-hydroxyprogesterone caproate. N Engl J Med 2003 348 2379-2385
8. Keirse M J. Progestogen administration in pregnancy may prevent preterm delivery. Br J Obstet Gynaecol 1990 97 149-154
9. Fleuren M AH, Wiefferink C H., Paulussen T GWM. Implementing Innovations in Health Care Organizations: Enhancing and Impeding Factors. Leiden TNO Preventie en Gezondheid 2002
10. Verloskundig Vademecum 2003. Diemen College voor Zorgverzekeringen 2003
11. Ness A, Dias T, Damus K, Burd I, Berghella V. Impact of the recent randomized trials on the use of progesterone to prevent preterm birth: a 2005 follow-up survey. Am J Obstet Gynecol 2006 195 1174-1179
12. Ness A, Baxter J, Hyslop T, Berghella V. Progesterone for preventing premature birth: practice patterns of board-certified maternal-fetal medicine specialists in the United States. J Reprod Med 2006 51 411-415
13. Grol R. Personal paper. Beliefs and evidence in changing clinical practice. BMJ 1997 315 418-421
14. Bero L A., Grilli R, Grimshaw J M., Harvey E, Oxman A D., Thomson M A., The Cochrane Effective Practice and Organization of Care Review Group. Closing the gap between research and practice: an overview of systematic reviews of interventions to promote the implementation of research findings. BMJ 1998 317 465-468
15. Grimshaw J M., Thomas R E., MacLennan G et al. Effectiveness and efficiency of guideline dissemination and implementation strategies. Health Technol Assess 2004 8 1-72
16. Oxman A D., Thomson M A., Davis D A., Haynes R B. No magic bullets: a systematic review of 102 trials of interventions to improve professional practice. CMAJ 1995 153 1423-1431
17. Greco P J., Eisenberg J M. Changing physicians' practices. N Engl J Med 1993 329 1271-1273